Cancer BiologybioRxivPreprint
Targeting Tumor-intrinsic TAK1 triggers anti-tumor immunity and sensitizes pancreatic cancer to checkpoint blockade
Sapana Bansod, Timothy Hung-Po Chen, Vikas Somani…·Kian‐Huat Lim
This study identifies TAK1 as a therapeutic target in pancreatic cancer that enhances anti-tumor immunity and sensitizes tumors to checkpoint blockade.